Article info
PDFInterventional cardiology and surgery
Role of oral rapamycin to prevent restenosis in patients with de novo lesions undergoing coronary stenting: results of the Argentina single centre study (ORAR trial)
- Correspondence to:
Dr Alfredo E Rodriguez
Cardiac Unit, Otamendi Hospital, Azcuénaga 870, Buenos Aires, Argentina C1115 AAB; centrocecision.com
Citation
Role of oral rapamycin to prevent restenosis in patients with de novo lesions undergoing coronary stenting: results of the Argentina single centre study (ORAR trial)
Publication history
- Accepted January 27, 2005
- First published March 17, 2005.
Online issue publication
March 15, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by Heart